Complementary, holistic, and integrative medicine: Crohn disease

Alycia Leiby, Minal Vazirani

Research output: Contribution to journalShort survey

1 Citation (Scopus)

Abstract

• Although the use of CAM in pediatric CD is common, quality evidence-based research is limited. There is clearly a need for further randomized controlled trials. • The role of psychosocial distress in children with CD should not be overlooked and thus biobehavioral techniques should be considered and incorporated when possible. • Considering the potential for growth failure and need for surgical intervention in CD, any CAM therapies that are not harmful should be used only in combination with conventional medical treatment. • The importance of all health care providers partnering with their patients and asking about CAM use, as well as maintaining an awareness of efficacy, safety, harm, drug-supplement interactions, and appropriate referral sources, should be kept in mind when caring for those afflicted with this chronic disease.

Original languageEnglish (US)
Pages (from-to)83-85
Number of pages3
JournalPediatrics in Review
Volume33
Issue number2
DOIs
StatePublished - Feb 1 2012

Fingerprint

Integrative Medicine
Holistic Health
Complementary Therapies
Crohn Disease
Drug Interactions
Health Personnel
Chronic Disease
Referral and Consultation
Randomized Controlled Trials
Pediatrics
Safety
Therapeutics
Growth
Research

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{95f40e6ac96d438a80cf873fad8b7f55,
title = "Complementary, holistic, and integrative medicine: Crohn disease",
abstract = "• Although the use of CAM in pediatric CD is common, quality evidence-based research is limited. There is clearly a need for further randomized controlled trials. • The role of psychosocial distress in children with CD should not be overlooked and thus biobehavioral techniques should be considered and incorporated when possible. • Considering the potential for growth failure and need for surgical intervention in CD, any CAM therapies that are not harmful should be used only in combination with conventional medical treatment. • The importance of all health care providers partnering with their patients and asking about CAM use, as well as maintaining an awareness of efficacy, safety, harm, drug-supplement interactions, and appropriate referral sources, should be kept in mind when caring for those afflicted with this chronic disease.",
author = "Alycia Leiby and Minal Vazirani",
year = "2012",
month = "2",
day = "1",
doi = "10.1542/pir.33-2-83",
language = "English (US)",
volume = "33",
pages = "83--85",
journal = "Pediatrics in Review",
issn = "0191-9601",
publisher = "American Academy of Pediatrics",
number = "2",

}

Complementary, holistic, and integrative medicine : Crohn disease. / Leiby, Alycia; Vazirani, Minal.

In: Pediatrics in Review, Vol. 33, No. 2, 01.02.2012, p. 83-85.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Complementary, holistic, and integrative medicine

T2 - Crohn disease

AU - Leiby, Alycia

AU - Vazirani, Minal

PY - 2012/2/1

Y1 - 2012/2/1

N2 - • Although the use of CAM in pediatric CD is common, quality evidence-based research is limited. There is clearly a need for further randomized controlled trials. • The role of psychosocial distress in children with CD should not be overlooked and thus biobehavioral techniques should be considered and incorporated when possible. • Considering the potential for growth failure and need for surgical intervention in CD, any CAM therapies that are not harmful should be used only in combination with conventional medical treatment. • The importance of all health care providers partnering with their patients and asking about CAM use, as well as maintaining an awareness of efficacy, safety, harm, drug-supplement interactions, and appropriate referral sources, should be kept in mind when caring for those afflicted with this chronic disease.

AB - • Although the use of CAM in pediatric CD is common, quality evidence-based research is limited. There is clearly a need for further randomized controlled trials. • The role of psychosocial distress in children with CD should not be overlooked and thus biobehavioral techniques should be considered and incorporated when possible. • Considering the potential for growth failure and need for surgical intervention in CD, any CAM therapies that are not harmful should be used only in combination with conventional medical treatment. • The importance of all health care providers partnering with their patients and asking about CAM use, as well as maintaining an awareness of efficacy, safety, harm, drug-supplement interactions, and appropriate referral sources, should be kept in mind when caring for those afflicted with this chronic disease.

UR - http://www.scopus.com/inward/record.url?scp=84860830659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860830659&partnerID=8YFLogxK

U2 - 10.1542/pir.33-2-83

DO - 10.1542/pir.33-2-83

M3 - Short survey

C2 - 22301034

AN - SCOPUS:84860830659

VL - 33

SP - 83

EP - 85

JO - Pediatrics in Review

JF - Pediatrics in Review

SN - 0191-9601

IS - 2

ER -